hormona glp 1 alimentos Guía de Alimentación para uso GLP-1, #trulicity , #saxenda , #mounjaro , #ozempic , #vegoya , #chile , #endocrinología GLP‑1: la hormona que regula

In terms of valuation, Eli Lilly's PE - TTM on June 24 was 66x

Check out our latest blog post for our breakdown on what makes GLP-1s unique, what to watch for in the upcoming model, and why this matters for manufacturers, payers, and policymakers alike: #CMMI #Pharmaceuticals #HealthPolicy #GLP1 #DrugPricing To view or add a comment, sign in More Relevant Posts GLP-1 therapies are transforming care and sparking major policy questions

Theoretical risks are extrapolated from IGF-1 biology: Hypoglycemia : IGF-1 shares structural homology with insulin and can activate insulin receptors, particularly at high concentrations Growth factor signaling : Sustained IGF-1R activation carries theoretical oncogenic potential, as the IGF-1 axis promotes cell proliferation and survival Systemic effects : Reduced IGFBP binding means greater systemic exposure to active growth factor, potentially amplifying both therapeutic and adverse effects Organ-specific : Potential for cardiac hypertrophy and other tissue growth with chronic exposure MGF Side Effects# MGF safety data are limited to preclinical observations: Rapid clearance : The very short half-life limits systemic exposure, which may reduce off-target effects Local action : Endogenous MGF acts primarily as a local paracrine factor, suggesting that targeted administration may have a favorable safety profile No human data : Without clinical trials, the safety profile in humans remains undefined Proliferative concerns : As a satellite cell activator, theoretical concerns exist regarding uncontrolled proliferation, though preclinical data have not demonstrated this Dosing and Administration Comparison# IGF-1 LR3 Dosing# MGF Dosing# The short half-life of native MGF is a significant practical limitation

Thats why we developed our ETHICS check